Key Metrics 
Check Before You Invest 
10 Yrs X-Ray 
Valuation 
Analyst Note 
Qtr. Results 
Financials 
News 
About
Cravatex Ltd (CRAVATEX)
Share Analysis – Quality, Valuation Zone, Price Trend & DeciZen Rating BSE: 509472 NSE: CRAVATEX Trading | Small Cap | Cravatex Share Price
₹320 1.00 (0.31%)
As on 16-Sep'26 09:21
Cravatex Ltd (CRAVATEX)
Share Analysis – Quality, Valuation Zone, Price Trend & DeciZen Rating BSE: 509472 NSE: CRAVATEX Trading | Small Cap | Cravatex Share Price
₹320 1.00 (0.31%)
As on 16-Sep'26 09:21
Key Metrics
Valuation Multiples
Market Cap
₹82 Cr.
Current Price
₹320
52-Week Low / High
₹300 / 436
TTM EPS
₹33.3
TTM Sales
₹160 Cr.
Book Value per Share
₹463.9
P/E Ratio
9.58
Lower than its 5-year historical median
Industry PE
38.9
Price to Book (P/B)
0.69
Lower than its 5-year historical median
Price to Sales (P/S)
0.52
Lower than its 5-year historical median
EV/EBITDA
0.47
Lower than its 5-year historical median
Dividend Yield
4.06%
Profitability Efficiency
Return on Equity (ROE)
6.02%
Outperforms industry median
Return on Capital Employed (ROCE)
7.92%
Outperforms industry median
Return on Assets (ROA)
4.74%
Operating Profit Margin
-4.2%
Net Profit Margin
4.5%
Gross Profit Margin
6.7%
Growth Momentum
1-yr vs 3-yr growth
1-yr vs 3-yr growth
Sales Growth (1 Year)
Improving versus 3-year growth rate
47.92%
Operating Profit Growth (1 Year)
-
-
Net Profit Growth (1 Year)
Improving versus 3-year growth rate
40.79%
Asset Quality
Promoter Holding
75.00%
Pledged shares (%) of Promoter's holding (%)
0.00%
Reserves
₹117 Cr.
Equity
₹2.6 Cr.
Face Value
₹10
All Time Low / High
₹3.12 / 799.00
Check Before You Invest
M-Cap below 100cr DeciZen not available
Is Cravatex Ltd a good quality company?
Cravatex Ltd is a quality company, based on a multi-year financial track record.
This assessment is based on company’s performance on Revenue growth, ROCE, Equity and Assets, key margin ratios, cash conversion cycle, and debt to cash flow from operations and how it compares with its long term averages.
We have analysed the performance of the company on the following:
-
How has it performed on generating Profits?
By checking its Revenue growth, Gross, Operating and Net Margins compared to its last 5-year median.
-
How efficiently has it utilized Capital?
By checking its ROCE, ROA, ROE and its Cash Conversion Cycle.
-
How is it managing its Debt?
By checking its Debt to Equity and Cash Flow from Operations.
How does Cravatex Ltd performance compare with that of its Peers?
Revenue growth of Cravatex Ltd vs industry peers?
Cravatex Ltd revenue CAGR is -22.28%, compared to the industry median CAGR of 0%, indicating slower growth and losing its market share.
Promoter shareholding and pledge status of Cravatex Ltd?
Promoters hold 75.00% of the Cravatex Ltd, with 0.00% of their stake pledged, indicating no pledge risk.
Stock return of Cravatex Ltd over the last decade?
Over the last 9 year(s), the stock has delivered a CAGR of 4.1% based on the current price.
10 Year X-Ray :
Analysis of Financial Track Record (Data adjusted to bonus, split, extra-ordinary income, rights issue and change in financial year end)
Data adjusted to bonus, split, extra-ordinary income, rights issue and change in financial year endData adjusted to bonus, split, extra-ordinary income, rights issue and change in financial year end.
What is a Financial Track Record? How to read this chart in order to understand the data present here?
Financial track record gives insight into the company's performance on key parameters over the past ten years. MoneyWorks4me’s proprietary colour codes make it easy for retail investors to gauge the company’s past performance.
Cravatex Ltd has performed well in some of the past ten years indicating its past ten year financial track record is somewhat good
Value Creation ⓘ
| Mar'17 | Mar'18 | Mar'19 | Mar'20 | Mar'21 | Mar'22 | Mar'23 | Mar'24 | Mar'25 | Mar'26 | TTM | |
|---|---|---|---|---|---|---|---|---|---|---|---|
| ROCE % ⓘ | 4.1% | 3.6% | 10.3% | 9% | 17.2% | 13.2% | -87.3% | 23.7% | 29.8% | 26.9% | - |
| Value Creation Index ⓘ | -0.7 | -0.7 | -0.3 | -0.4 | 0.2 | -0.1 | -7.2 | 0.7 | 1.1 | 0.9 | - |
Growth Parameters ⓘ |
|||||||||||
| Sales ⓘ | 157 | 0.7 | 1 | 2.4 | 2.3 | 2.4 | 3.5 | 1.9 | 4.8 | 7.1 | 7 |
| Sales YoY Gr. | - | -99.5% | 40.5% | 132.7% | -4.6% | 5.6% | 42.6% | -46.3% | 156.7% | 47.9% | - |
| Adj EPS ⓘ | -25.6 | 1.6 | 8.8 | 9 | 22.6 | 16.9 | -18.8 | 13.6 | 18.7 | 21.2 | 21.4 |
| YoY Gr. | - | NA | 437.4% | 2.4% | 152.1% | -25.4% | -211.4% | NA | 37.2% | 13.3% | - |
| BVPS (₹) ⓘ | 112.9 | 115.5 | 123.2 | 128 | 149.2 | 163.2 | 55.2 | 67.5 | 83.2 | 92.1 | 93.7 |
| Adj Net Profit ⓘ | -6.6 | 0.4 | 2.3 | 2.3 | 5.8 | 4.4 | -4.9 | 3.5 | 4.8 | 5.5 | 6 |
| Cash Flow from Ops. ⓘ | 104 | -3 | -1.2 | -2 | -2 | -3.2 | -5.2 | -2.5 | -3.4 | -2.5 | - |
| Debt/CF from Ops. ⓘ | 0.1 | -3.2 | -5.1 | -2 | -2 | -1.3 | 0 | 0 | 0 | 0 | - |
CAGR ⓘ
| 9 Years | 5 Years | 3 Years | 1 Years | |||||
|---|---|---|---|---|---|---|---|---|
| Sales ⓘ | -29.1% | 25.2% | 26.8% | 47.9% | ||||
| Adj EPS ⓘ | NA | -1.3% | NA | 13.3% | ||||
| BVPSⓘ | -2.2% | -9.2% | 18.6% | 10.7% | ||||
| Share Price | 4.2% | -5.8% | -7% | -24.1% | ||||
Key Financial Parameters ⓘ
| Mar'17 | Mar'18 | Mar'19 | Mar'20 | Mar'21 | Mar'22 | Mar'23 | Mar'24 | Mar'25 | Mar'26 | TTM | |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Return on Equity % ⓘ | -21.5 | 1.4 | 7.3 | 7.1 | 16.3 | 10.8 | -17.2 | 22.2 | 24.8 | 24.2 | 23 |
| Op. Profit Mgn % ⓘ | -1.3 | -360.9 | -216.2 | -120.1 | -100.9 | -91.2 | -79.3 | -122.3 | -55.8 | -32.9 | -25.4 |
| Net Profit Mgn % ⓘ | -4.2 | 56.9 | 217.8 | 95.8 | 253.2 | 178.4 | -139.5 | 188.2 | 100.8 | 77.2 | 77.6 |
| Debt to Equity ⓘ | 0.3 | 0.3 | 0.2 | 0.1 | 0.1 | 0.1 | 0 | 0 | 0 | 0 | - |
| Working Cap Days ⓘ | 152 | 1,926 | 835 | 260 | 257 | 264 | 296 | 519 | 132 | 78 | 133 |
| Cash Conv. Cycle ⓘ | 95 | 667 | 152 | 30 | 23 | 4 | -0 | 3 | -6 | -4 | 119 |
Valuation of Cravatex - Consolidated
Analyst's Notes
No data found!
Management X-Ray
Shareholding Pattern
Promoter's Holding & Share Pledging
| Pledged * | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
* Pledged shares as % of Promoter's holding (%)
Financials
| PARTICULARS | Mar'17 | Mar'18 | Mar'19 | Mar'20 | Mar'21 | Mar'22 | Mar'23 | Mar'24 | Mar'25 | Mar'26 |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales | 266.10 | 355.80 | 717.66 | 864.65 | 531.88 | 594.33 | 503.66 | 202.63 | 173.76 | 150.87 |
| Operating Expenses ⓘ + | 270.73 | 361.41 | 693.60 | 843.41 | 543.76 | 597.62 | 533.55 | 210.28 | 175.45 | 157.26 |
| Operating Profit ⓘ | -4.63 | -5.61 | 24.06 | 21.24 | -11.88 | -3.29 | -29.89 | -7.65 | -1.68 | -6.39 |
| Operating Profit Margin (%) | -1.7% | -1.6% | 3.4% | 2.5% | -2.2% | -0.6% | -5.9% | -3.8% | -1.0% | -4.2% |
| Other Income ⓘ + | 3.53 | 4.26 | 4.21 | 5.26 | 14.31 | 15.28 | 12.47 | 16.10 | 9.95 | 16.84 |
| Interest ⓘ | 10.67 | 5.01 | 5.65 | 13.94 | 14.74 | 14.17 | 13.81 | 0.41 | 0.41 | 0.36 |
| Depreciation ⓘ | 3.40 | 5.73 | 5.73 | 14.98 | 17.44 | 16.37 | 16.14 | 1.88 | 1.48 | 1.51 |
| Profit Before Tax ⓘ | -15.17 | -12.09 | 16.88 | -2.43 | -29.75 | -18.54 | 58.33 | 6.16 | 6.37 | 8.58 |
| Tax ⓘ | -1.30 | 0.24 | 6.22 | 2.29 | 0.86 | 1.34 | -0.60 | 1.33 | 1.54 | 1.78 |
| Profit After Tax | -13.87 | -12.34 | 10.66 | -4.71 | -30.61 | -19.89 | 58.93 | 4.83 | 4.83 | 6.80 |
| PAT Margin (%) | -5.2% | -3.5% | 1.5% | -0.6% | -5.8% | -3.4% | 11.7% | 2.4% | 2.8% | 4.5% |
| Adjusted EPS (₹) | -53.7 | -47.7 | 41.3 | -18.2 | -118.0 | -77.0 | 228.1 | 18.7 | 18.7 | 26.3 |
| Dividend Payout Ratio (%) | 0% | -2.10% | 4.90% | -16.50% | -2.50% | -3.90% | 0.70% | 16.10% | 66.90% | 49.40% |
| PARTICULARS | Mar'17 | Mar'18 | Mar'19 | Mar'20 | Mar'21 | Mar'22 | Mar'23 | Mar'24 | Mar'25 | Mar'26 | |
|---|---|---|---|---|---|---|---|---|---|---|---|
Equity and Liabilities | |||||||||||
| Shareholders Fund + | 21.87 | 9.33 | 19.78 | -1.02 | -28.28 | -49.77 | 92.36 | 98.72 | 106.43 | 119.44 | |
| Debt + | 134.68 | 105.04 | 116.68 | 160.71 | 154.66 | 167.13 | 0 | 0 | 0 | 0 | |
| Minority Interest | 0 | 0 | -0 | 71.09 | 75.24 | 75.24 | 0 | 0 | 0 | 0 | |
| Trade Payables | 32.49 | 60.88 | 22.55 | 42.07 | 22.97 | 40.14 | 21.26 | 9.56 | 12.56 | 8.06 | |
| Others Liabilities ⓘ | 30.84 | 33.20 | 140.19 | 169.05 | 160.51 | 131.84 | 23.03 | 16.14 | 21.71 | 18.70 | |
| Total Liabilities ⓘ | 219.87 | 208.45 | 299.20 | 441.91 | 385.10 | 364.59 | 136.65 | 124.43 | 140.70 | 146.20 | |
Fixed Assets | |||||||||||
| Net Fixed Assets ⓘ + | 46.06 | 40.93 | 40.99 | 85.73 | 70.21 | 55.45 | 3.12 | 4.01 | 4.40 | 3.46 | |
| CWIP ⓘ | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | |
| Investments ⓘ | 7.06 | 12.97 | 7.73 | 30.97 | 21.04 | 4.60 | 4.62 | 8.09 | 15.89 | 18.72 | |
| Inventories | 41.61 | 36.28 | 83.72 | 81.61 | 85 | 94.34 | 29.04 | 10.67 | 11.48 | 23.01 | |
| Trade Receivables | 61.02 | 103.27 | 150.03 | 169.43 | 143.05 | 133.21 | 26.21 | 13.85 | 23.96 | 16.33 | |
Cash Equivalents 
ⓘ
| 56.81 | 6.83 | 5.28 | 49.32 | 36.07 | 37.97 | 56.32 | 76.05 | 75.45 | 76.62 | |
| Others Assets ⓘ | 7.31 | 8.18 | 11.45 | 24.85 | 29.73 | 39.02 | 17.33 | 11.77 | 9.53 | 8.06 | |
| Total Assets ⓘ | 219.87 | 208.45 | 299.20 | 441.91 | 385.10 | 364.59 | 136.65 | 124.43 | 140.70 | 146.20 | |
| PARTICULARS | Mar'17 | Mar'18 | Mar'19 | Mar'20 | Mar'21 | Mar'22 | Mar'23 | Mar'24 | Mar'25 | Mar'26 |
|---|---|---|---|---|---|---|---|---|---|---|
| Cash Flow From Operating Activity ⓘ + | 35.33 | -12.51 | -4.69 | 32.02 | -3.82 | -7.56 | 143.54 | 19.06 | 2.99 | 1.27 |
| Cash Flow From Investing Activity ⓘ + | -24.18 | -4.47 | 3.30 | -37.33 | 20.55 | 13.93 | 42.42 | -1.32 | -0.64 | 3.29 |
| Cash Flow From Financing Activity ⓘ + | 38.39 | -34.06 | -0.25 | 37.43 | -20.71 | -3.69 | -167.59 | -0.39 | -0.78 | -3.23 |
| Net Cash Flow ⓘ | 49.54 | -51.04 | -1.64 | 32.12 | -3.98 | 2.68 | 18.36 | 17.35 | 1.57 | 1.33 |
| PARTICULARS | Mar'17 | Mar'18 | Mar'19 | Mar'20 | Mar'21 | Mar'22 | Mar'23 | Mar'24 | Mar'25 | Mar'26 |
|---|---|---|---|---|---|---|---|---|---|---|
| Ratios | ||||||||||
| ROE (%) | -48.34 | -80.11 | 73.26 | N/A | N/A | N/A | 276.7 | 5.05 | 4.71 | 6.02 |
| ROCE (%) | -3.41 | -5.24 | 17.96 | N/A | N/A | N/A | 68.8 | 6.87 | 6.62 | 7.92 |
| Asset Turnover Ratio | 1.35 | 1.66 | 2.83 | 2.33 | 1.29 | 1.59 | 2.01 | 1.55 | 1.31 | 1.05 |
| PAT to CFO Conversion(x) | N/A | N/A | -0.44 | N/A | N/A | N/A | 2.44 | 3.95 | 0.62 | 0.19 |
| Working Capital Days | ||||||||||
| Receivable Days | 92.50 | 84.30 | 64.40 | 67.40 | 107.20 | 84.80 | 57.80 | 36.10 | 39.70 | 48.70 |
| Inventory Days | 67.20 | 40 | 30.50 | 34.90 | 57.20 | 55.10 | 44.70 | 35.80 | 23.30 | 41.70 |
| Payable Days | 65.10 | 68.30 | 29.80 | 19.50 | 32.60 | 28 | 31 | 40.40 | 38.20 | 49.50 |
Top 5 Mutual Funds Holding
Last Visited Stocks
Announcements
Cravatex Ltd FAQs
The current trading price of Cravatex on 16-Sep-2026 09:21 is ₹320.0.
Market capitalization or market cap is determined by multiplying the current market price of a company's shares with the total number of shares outstanding. As of 15-Sep-2026 the market cap of Cravatex stood at ₹82.43 Cr
The latest P/E ratio of Cravatex as of 15-Sep-2026 is 14.94.
The latest P/B ratio of Cravatex as of 15-Sep-2026 is 3.40.
The 52-week high of Cravatex is ₹435.8 and the 52-week low is ₹300.0.
The TTM revenue is Trailing Twelve Months sales. The TTM revenue/sales of Cravatex is ₹7.10 ( Cr.) .
Past 10 year's financial track record analysis by Moneyworks4me indicates that Cravatex Ltd is a average quality company.
The key valuation ratios of Cravatex Ltd's currently when compared to its past seem to suggest it is in the Fair zone.
The Price Trend analysis by MoneyWorks4Me indicates it is Weak which suggest that the price of Cravatex Ltd is likely to Fall in the short term. However, please check the rating on Quality and Valuation before investing.
About Cravatex Ltd
Cravatex Limited Company was incorporated in 1951. The company imports and distributes products of various brands, such as Johnson, Horizon, Vision, Body Solid, and Magnum. The company also distributes sports shoes and apparels, tennis balls, tennis rackets, and massage chairs and accessories. In addition, it manufactures and sells sports and casual wear.
It is one of the largest chains of dyers and dry cleaners of it's time. Along with these ventures, the company has also diversified into textile processing and printing. In keeping with the developments in the worlds of fitness and health the company expanded into the manufacture of sports and casual wear, culminating recently, in the distribution of fitness equipment for home and commercial use.
The company represents several reputed international brands of fitness equipment in India and is the only ISO certified & public listed company in this field. The company, therefore, has now integrated beauty therapy into its already versatile list of services. The company offers a range of advanced international beauty therapies within spas across the country as well as providing clients with high-end beauty products from one of the leading beauty product manufacturers in the world. The company continues its presence in the Garment Exports Market and the domestic footwear market where it caters to the needs of several international brands.
Group Companies, Proline Exports and Pro Apparels, focus on the manufacture and marketing of premium quality garments, for some of the most discerning customers in the world.
The companies track fashion trends and research new products globally, before shipping to an impressive list of clients. The list includes top urban fashion brands including Azzure; an urban fashion based sportswear collection, Bullrot; a French clothing company which designs trendy street wear, and Phyne Clothing; a female urban clothing brand. Among the sporting brands are Wilson, Fila, Ocean Pacific and Russell Athletic.
It contributes to the distribution of major international brands Fila, Slazenger and Nassau. Fila Sport Spa (Italy) in sports section. In footwear it distributes shoes of JoggerS, Lifestyle, running, sandals tennis shoes. In raquet sports it offers tennis balls, tennis rackets.
Thec company launched Proline Fitness in 1996 which was a pioneer in introducing the personal range of fitness equipments to the Indian Market. Proline Fitness is the sole importer and distributor for several international brands like Johnson (the 4th Largest Fitness Equipment Manufacturer in the World), Horizon, Vision, Body Solid and Magnum. It has a complete range of fitness equipment for home as well as commercial use.
The sports division of the company includes footware, accessories and raquet sports while the fitness division includes home and commercial products
2011 - Company successfully concluded negotiation to extend the Sub License Agreement for the use of "FILA" trademark for India, Bangladesh, Pakistan and Sri Lanka.
2012 - The Company has successfully concluded negotiations with the brand owner and has reached a mutual agreement to extend the Sub-license Agreement for the use of "FILA" trademark for India, Bangladesh, Pakistan and Sri Lanka.
You have 49 views remaining as a Guest User. To get DeciZen Rating of 3,500+ Stocks based on their Quality, Valuation and Price Trend Login Now
